CASE-REPORT OF INTERFERON-ALFA THERAPY FOR MULTIPLE-MYELOMA DURING PREGNANCY

Interferon alfa is broadly accepted as treatment for multiple myeloma, but its potential teratogenicity and mutagenicity during pregnancy in the human are still in dispute. We report a case of successful delivery after interferon alfa therapy for multiple myeloma during the first trimester of pregnancy. We reviewed the cases of interferon alfa treatment given during pregnancy for a malignancy and discovered that all of them have had successful deliveries and normal healthy babies. Additional studies should be encouraged to confirm the safety of interferon alfa therapy during pregnancy.